RxDoctor Payments Data

Daniella Stearns

Family · Clinton, TNNPI 1578103123

Payments from drug & device makers

$5,147in general payments, 2019–2025

Across 364 payments — averaging $14.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$896
  • Lilly USA, LLC$450
  • Amgen$314
  • AstraZeneca$244
  • Takeda Pharmaceuticals U.S.A., Inc.$241
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$5,147100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,147 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide54$86,583
JanuviaSitagliptin Phosphate11$10,862
MyrbetriqMirabegron11$5,253
Pravastatin Sodium51$713
Levothyroxine Sodium74$681
Ondansetron OdtOndansetron20$670
Diclofenac Sodium41$595
Buspirone Hcl35$590
Valsartan11$538
Albuterol Sulfate HfaAlbuterol Sulfate19$492
Pantoprazole Sodium43$445
Gabapentin28$419
Amitriptyline Hcl24$405
Omeprazole28$374
Atorvastatin Calcium36$353

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,068$86,58354 claims
MerckJanuvia$166$10,86211 claims
Astellas Pharma US IncMyrbetriq$70$5,25311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Clinton

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →